Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company	Revenue ▾	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS
ARCT	Arcturus Therapeutics Holdings Inc. Manufacturing · Year ended 2025-12-31 · USD	$82.03M	-$65.78M	-80.2%	-30.7%	-46.1%	-$2.40
ADCT	ADC Therapeutics SA Manufacturing · Year ended 2025-12-31 · USD	$81.36M	-$142.62M	-175.3%	n/a	14.9%	-$1.12
ETON	Eton Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$79.95M	-$4.60M	-5.8%	-17.6%	104.9%	n/a
CTMX	CytomX Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$76.20M	-$17.37M	-22.8%	-17.5%	-44.8%	n/a
ABCL	AbCellera Biologics Inc. Manufacturing · Year ended 2025-12-31 · USD	$75.13M	-$146.41M	-194.9%	-15.1%	160.6%	-$0.49
BCYC	Bicycle Therapeutics PLC Manufacturing · Year ended 2025-12-31 · USD	$72.59M	-$218.96M	-301.7%	-35.9%	105.8%	-$3.16
ASMB	Assembly Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$72.30M	-$6.12M	-8.5%	-3.0%	153.5%	-$0.55
VRDN	Viridian Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$70.85M	-$342.60M	-483.6%	-47.4%	n/m	n/a
RMTI	Rockwell Medical, Inc. Manufacturing · Year ended 2025-12-31 · USD	$69.26M	-$5.31M	-7.7%	-14.4%	-31.8%	-$0.15
KURA	Kura Oncology, Inc. Manufacturing · Year ended 2025-12-31 · USD	$67.48M	-$278.67M	-412.9%	-160.0%	25.2%	-$3.18
SPRO	Spero Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$66.80M	$8.57M	12.8%	14.5%	39.2%	$0.15
ENTA	Enanta Pharmaceuticals Inc Manufacturing · Year ended 2025-09-30 · USD	$65.32M	-$81.89M	-125.4%	-126.5%	-3.4%	-$3.84
FBIO	Fortress Biotech, Inc. Manufacturing · Year ended 2025-12-31 · USD	$63.26M	$6.82M	10.8%	13.7%	9.7%	-$0.07
NUVB	Nuvation Bio Inc. Manufacturing · Year ended 2025-12-31 · USD	$62.90M	-$204.63M	-325.3%	-66.9%	699.0%	-$0.60
TNGX	Tango Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$62.38M	-$101.59M	-162.9%	-29.3%	48.3%	-$0.87
DERM	Journey Medical Corp Manufacturing · Year ended 2025-12-31 · USD	$61.24M	-$11.43M	-18.7%	-35.9%	11.1%	-$0.47
AYTU	Aytu Biopharma, Inc Manufacturing · Year ended 2026-06-30 · USD	$57.57M	-$14.25M	-24.8%	-40.4%	-13.3%	n/a
NKTR	Nektar Therapeutics Manufacturing · Year ended 2025-12-31 · USD	$55.23M	-$164.08M	-297.1%	-182.6%	-43.9%	-$9.73
AGIO	Agios Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$54.03M	-$412.78M	-764.0%	-34.6%	48.0%	-$7.12
QTTB	Q32 Bio Inc. Manufacturing · Year ended 2025-12-31 · USD	$53.74M	$29.82M	55.5%	71.0%	n/a	$2.42
OCUL	Ocular Therapeutix, Inc Manufacturing · Year ended 2025-12-31 · USD	$51.95M	-$265.94M	-511.9%	-40.6%	-18.5%	-$1.42
LXRX	Lexicon Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$49.80M	-$50.34M	-101.1%	-46.8%	60.2%	-$0.14
GOSS	Gossamer Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	$48.47M	-$170.37M	-351.5%	n/a	-57.7%	-$0.75
PTGX	Protagonist Therapeutics, Inc Manufacturing · Year ended 2025-12-31 · USD	$46.02M	-$130.15M	-282.8%	-21.2%	-89.4%	-$2.05
SEPN	Septerna, Inc. Manufacturing · Year ended 2025-12-31 · USD	$45.95M	-$48.88M	-106.4%	-12.8%	n/m	-$1.10

Rows per page: 2550 100